glp-1 ra drugs list Drug Comparison in Diabetes and Obesity Treatment Glucagon-like peptide-1 receptor: mechanisms and
Description
[DOI] [PubMed] [Google Scholar] 129.Levin PA, Mersey JH, Zhou S, Bromberger LA
Instead, it imposes new requirements on entities the board already oversees
Preserving muscle mass helps boost metabolism as you lose fat
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
July 10, 2024
